Birdwatch Note Rating
2021-10-04 00:03:47 UTC - HELPFUL
Rated by Participant: E9FA3618E5EF5961394CD4D435DC2E992A6071E7CE9DA8B0D2776210EB1164CA
Participant Details
Original Note:
Remdesivir is recommended for use in COVID-19 patients with acute renal failure. There is no clinical benefit in the treatment of COVID-19 with hydroxychloroquine. There is insufficient evidence to support the use of Ivermectin for COVID-19 treatment. https://jasn.asnjournals.org/content/32/2/518 https://www.covid19treatmentguidelines.nih.gov/therapies/antiviral-therapy/chloroquine-or-hydroxychloroquine-and-or-azithromycin/ https://www.covid19treatmentguidelines.nih.gov/therapies/antiviral-therapy/ivermectin/
All Note Details